Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.57 - $0.88 $155,670 - $240,333
273,106 Added 69.26%
667,418 $580,000
Q1 2023

May 15, 2023

BUY
$0.61 - $1.03 $4,880 - $8,240
8,000 Added 2.07%
394,312 $276,000
Q4 2022

Feb 13, 2023

BUY
$0.62 - $1.21 $8,492 - $16,574
13,698 Added 3.68%
386,312 $316,000
Q3 2022

Nov 14, 2022

BUY
$1.05 - $2.1 $23,313 - $46,626
22,203 Added 6.34%
372,614 $387,000
Q2 2022

Aug 12, 2022

SELL
$1.42 - $3.15 $356,942 - $791,809
-251,368 Reduced 41.77%
350,411 $574,000
Q1 2022

May 13, 2022

SELL
$2.65 - $5.08 $214,846 - $411,855
-81,074 Reduced 11.87%
601,779 $1.77 Million
Q4 2021

Feb 11, 2022

BUY
$4.73 - $7.9 $348,109 - $581,408
73,596 Added 12.08%
682,853 $3.26 Million
Q3 2021

Nov 12, 2021

BUY
$5.16 - $7.98 $599,777 - $927,563
116,236 Added 23.58%
609,257 $4.61 Million
Q2 2021

Aug 13, 2021

BUY
$6.45 - $9.09 $2.05 Million - $2.89 Million
318,084 Added 181.83%
493,021 $3.68 Million
Q1 2021

May 12, 2021

BUY
$7.25 - $13.82 $138,315 - $263,657
19,078 Added 12.24%
174,937 $1.36 Million
Q4 2020

Feb 12, 2021

BUY
$6.87 - $10.48 $174,607 - $266,359
25,416 Added 19.48%
155,859 $1.44 Million
Q3 2020

Nov 13, 2020

BUY
$5.06 - $7.23 $242,004 - $345,789
47,827 Added 57.89%
130,443 $900,000
Q2 2020

Aug 13, 2020

BUY
$1.57 - $6.56 $7,167 - $29,946
4,565 Added 5.85%
82,616 $541,000
Q3 2019

Nov 12, 2019

SELL
$1.4 - $2.84 $907 - $1,840
-648 Reduced 0.82%
78,051 $110,000
Q2 2019

Aug 14, 2019

SELL
$2.75 - $4.89 $122,639 - $218,074
-44,596 Reduced 36.17%
78,699 $221,000
Q1 2019

May 14, 2019

BUY
$4.11 - $5.88 $26,920 - $38,514
6,550 Added 5.61%
123,295 $588,000
Q4 2018

Feb 13, 2019

BUY
$3.65 - $10.69 $142,985 - $418,770
39,174 Added 50.5%
116,745 $494,000
Q3 2018

Nov 13, 2018

BUY
$8.92 - $17.83 $22,790 - $45,555
2,555 Added 3.41%
77,571 $848,000
Q2 2018

Aug 14, 2018

BUY
$12.83 - $17.41 $962,455 - $1.31 Million
75,016 New
75,016 $1.22 Million

Others Institutions Holding SURF

About Surface Oncology, Inc.


  • Ticker SURF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,034,000
  • Description
  • Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...
More about SURF
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.